GlassScriptPhysician profile
Maxine Flame Warren
NPI 1508216458
$2,570.91
in general payments reported to CMS, 2019-2025
23 companies · $881 in 2025
The $881 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.33 · 2020: $47.06 · 2021: $102 · 2022: $433 · 2023: $399 · 2024: $611 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,891.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $458.94 | 2021-2025 | Ilumya, Winlevi |
| Abbvie INC. | $342.55 | 2020-2025 | |
| Galderma Laboratories, L.P. | $245.48 | 2021-2025 | Nemluvio, Aklief |
| Ucb, INC. | $195.68 | 2023-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $195.67 | 2020-2025 | Taltz, Olumiant, Ebglyss |
| Genzyme Corporation | $144.59 | 2022-2025 | |
| Janssen Biotech, INC. | $124.04 | 2024-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $100.70 | 2022-2023 | Dupixent |
| Allergan, INC. | $97.33 | 2019 | |
| Organon LLC | $96.06 | 2025 | Vtama |
| Leo Pharma INC. | $78.75 | 2024-2025 | Adbry |
| Almirall LLC | $56.86 | 2022-2025 | Klisyri |
| Dermavant Sciences, INC. | $51.17 | 2023-2024 | Vtama |
| Revance Therapeutics, INC. | $49.64 | 2025 | Daxxify |
| Arcutis Biotherapeutics, INC. | $49.38 | 2023-2025 | Zoryve |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $46.71 | 2022-2023 | Sotyktu |
| Solta Medical, A Division of Bausch Health US, LLC | $46.18 | 2023-2025 | |
| Journey Medical Corporation | $41.02 | 2022-2024 | |
| Pfizer INC. | $39.71 | 2022-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $37.89 | 2023-2025 | Cabtreo, Jublia |
| Novartis Pharmaceuticals Corporation | $32.15 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $28.35 | 2025 | |
| Incyte Corporation | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxine Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.